Cryoport, Inc. Files Q2 2024 10-Q

TL;DR

Cryoport's Q2 2024 10-Q is in. Check financials.

AI Summary

Cryoport, Inc. filed its 10-Q for the period ending June 30, 2024. The filing details the company's financial performance and position. Key financial data points such as revenue, expenses, and net income/loss for the quarter and year-to-date periods are presented, alongside balance sheet information as of June 30, 2024.

Why It Matters

This 10-Q filing provides investors and analysts with the latest financial performance data for Cryoport, Inc., crucial for understanding the company's operational health and future prospects.

Risk Assessment

Risk Level: medium — 10-Q filings are standard financial reports, but the specific financial performance and market conditions detailed within can introduce varying levels of risk.

Key Numbers

• 20240630 — Reporting Period End Date (Indicates the end of the fiscal quarter for which financial data is reported.)
• 20240808 — Filing Date (The date the 10-Q was officially submitted to the SEC.)

Key Players & Entities

• Cryoport, Inc. (company) — Filer of the 10-Q
• 20240630 (date) — End of the reporting period
• 20240808 (date) — Filing date

FAQ

Key Financial Figures

• $0.001 — ge on which registered: Common Stock, $0.001 par value CYRX The Nasdaq Stock Mar

Filing Documents

• cyrx-20240630x10q.htm (10-Q) — 2643KB
• cyrx-20240630xex31d1.htm (EX-31.1) — 14KB
• cyrx-20240630xex31d2.htm (EX-31.2) — 13KB
• cyrx-20240630xex32d1.htm (EX-32.1) — 17KB
• cyrx-20240630x10q004.jpg (GRAPHIC) — 8KB
• 0001558370-24-011562.txt ( ) — 12241KB
• cyrx-20240630.xsd (EX-101.SCH) — 73KB
• cyrx-20240630_cal.xml (EX-101.CAL) — 98KB
• cyrx-20240630_def.xml (EX-101.DEF) — 315KB
• cyrx-20240630_lab.xml (EX-101.LAB) — 649KB
• cyrx-20240630_pre.xml (EX-101.PRE) — 531KB
• cyrx-20240630x10q_htm.xml (XML) — 2528KB

FINANCIAL INFORMATION

PART I. FINANCIAL INFORMATION

Financial Statements

ITEM 1. Financial Statements Condensed Consolidated Balance Sheets at June 30, 2024 (Unaudited) and December 31, 2023 3 Unaudited Condensed Consolidated Statements of Operations for the three and six months ended June 30, 2024 and 2023 4 Unaudited Condensed Consolidated Statements of Comprehensive Loss for the three and six months ended June 30, 2024 and 2023 5 Unaudited Condensed Consolidated Statements of Stockholders' Equity for the three and six months ended June 30, 2024 and 2023 6 Unaudited Condensed Consolidated Statements of Cash Flows for the six months ended June 30, 2024 and 2023 7 Notes to Condensed Consolidated Financial Statements (Unaudited) 8

Management's Discussion and Analysis of Financial Condition and Results of Operations

ITEM 2. Management's Discussion and Analysis of Financial Condition and Results of Operations 26

Quantitative and Qualitative Disclosures About Market Risk

ITEM 3. Quantitative and Qualitative Disclosures About Market Risk 37

Controls and Procedures

ITEM 4. Controls and Procedures 37

OTHER INFORMATION

PART II. OTHER INFORMATION 38

Legal Proceedings

ITEM 1. Legal Proceedings 38

Risk Factors

ITEM 1A. Risk Factors 38

Unregistered Sales of Equity Securities and Use of Proceeds

ITEM 2. Unregistered Sales of Equity Securities and Use of Proceeds 38

Defaults Upon Senior Securities

ITEM 3. Defaults Upon Senior Securities 38

Mine Safety Disclosures

ITEM 4. Mine Safety Disclosures 38

Other Information

ITEM 5. Other Information 38

Exhibits

ITEM 6. Exhibits 39

SIGNATURES

SIGNATURES 40 Table of Contents Cryoport, Inc. and Subsidiaries Condensed Consolidated Balance Sheets (in thousands, except share data) June 30, December 31, 2024 2023 (unaudited) ASSETS Current Assets: Cash and cash equivalents $ 46,458 $ 46,346 Short-term investments 380,684 410,409 Accounts receivable, net 40,160 42,074 Inventories 23,609 26,206 Prepaid expenses and other current assets 11,075 10,077 Total current assets 501,986 535,112 Property and equipment, net 86,653 84,858 Operating lease right-of-use assets 29,684 32,653 Intangible assets, net 178,388 194,382 Goodwill 52,384 108,403 Deposits 1,668 1,680 Deferred tax assets 1,578 656 Total assets $ 852,341 $ 957,744 LIABILITIES AND STOCKHOLDERS' EQUITY Current Liabilities: Accounts payable and other accrued expenses $ 24,805 $ 26,995 Accrued compensation and related expenses 10,690 11,409 Deferred revenue 1,317 1,308 Current portion of operating lease liabilities 5,299 5,371 Current portion of finance lease liabilities 365 286 Current portion of convertible senior notes, net of discount of $ 0.1 million 14,244 — Current portion of notes payable 110 149 Current portion of contingent consideration 3,055 92 Total current liabilities 59,885 45,610 Convertible senior notes, net of discount of $ 5.5 million and $ 7.0 million, respectively 355,665 378,553 Notes payable 1,258 1,335 Operating lease liabilities, net of current portion 26,523 29,355 Finance lease liabilities, net of current portion 1,137 954 Deferred tax liabilities 2,651 2,816 Other long-term liabilities 427 601 Contingent consideration, net of current portion 4,700 9,497 Total liabilities 452,246 468,721 Commitments and contingencies Stockholders' Equity: Preferred stock, $ 0.001 par value; 2,500,000 shares authorized: Class A convertible preferred stock - $ 0.001 par

View Full Filing

View this 10-Q filing on SEC EDGAR